Kia ora Jan,  

  

Thank you for your request for official information. The reference number
for your request is: H2022013775.  

  

As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  

  

If you have any queries related to this request, please do not hesitate to
get in touch. 

 

Ngā mihi 

  

OIA Services Team 

M[2]inistry of Health information releases 
U[3]nite against COVID-19 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. https://www.health.govt.nz/about-ministr...
3. https://covid19.govt.nz/

hide quoted sections

Tçnâ koe Jan,

 

Thank you for your follow up request under the Official Information Act
1982 (the Act) to Manatû Hauora (Ministry of Health) on 30 September 2022.
You asked:

 

“As I have been advised that the the Pfizer-BioNTech vaccine did not
undergo a clinical trial in New Zealand as it received approval from
Medsafe, could you please now advise the date when Medsafe granted
approval of the Pfizer-BioNTech vaccine.”

 

Information regarding the provisional approval of COVID-19 vaccines by
Medsafe is available online on the Medsafe website:

[1]https://www.medsafe.govt.nz/COVID-19/sta...   

 

Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.

Ngâ mihi

 

OIA Services Team

[3]www.health.govt.nz

[4]Ministry of Health information releases

[5]Unite against COVID-19

 

 

 

 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://www.medsafe.govt.nz/COVID-19/sta...
2. mailto:[email address]
3. http://www.health.govt.nz/
4. https://www.health.govt.nz/about-ministr...
5. https://covid19.govt.nz/

hide quoted sections